OTC Label Multiple Columns Suggested For Elongated Packaging By CHPA
This article was originally published in The Tan Sheet
Executive Summary
FDA should allow the use of more than two columns to present required information on OTC labeling for products with long rectangular packaging, Consumer Healthcare Products Association Senior VP and Director of Science & Technology William Soller, PhD, said at a "feedback" meeting on the OTC labeling final rule in Rockville, Md. June 29.
You may also be interested in...
OTC Label Exemptions With "Consistency In Format" May Be Allowed - FDA
Exemption requests from the OTC labeling rule may deviate from elements of the final requirements if they are consistent with the general format outlined in the reg, FDA's Robert DeLap, MD/PhD, said at a working group meeting on the issue in Rockville, Md. Sept. 17.
OTC Label Exemptions With "Consistency In Format" May Be Allowed - FDA
Exemption requests from the OTC labeling rule may deviate from elements of the final requirements if they are consistent with the general format outlined in the reg, FDA's Robert DeLap, MD/PhD, said at a working group meeting on the issue in Rockville, Md. Sept. 17.
FDA Aims To Resolve OTC Labeling Issues At Three Upcoming Meetings
FDA will meet with over-the-counter drug and cosmetics trade associations as many as three more times to discuss outstanding concerns regarding the OTC labeling final rule.